Aerovate Therapeutics Inc (NASDAQ: AVTE) – Not A Clear Buying Opportunity?
Aerovate Therapeutics Inc (AVTE) concluded trading on Thursday at a closing price of $2.72, with 4.8 million shares of worth about $13.07 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 3115.95% during that period and on April 24, 2025 the price saw a […]
